Does FULVESTRANT Cause Breast cancer recurrent? 219 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Breast cancer recurrent have been filed in association with FULVESTRANT (FULVESTRANT). This represents 1.2% of all adverse event reports for FULVESTRANT.
219
Reports of Breast cancer recurrent with FULVESTRANT
1.2%
of all FULVESTRANT reports
6
Deaths
37
Hospitalizations
How Dangerous Is Breast cancer recurrent From FULVESTRANT?
Of the 219 reports, 6 (2.7%) resulted in death, 37 (16.9%) required hospitalization, and 7 (3.2%) were considered life-threatening.
Is Breast cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FULVESTRANT. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does FULVESTRANT Cause?
Malignant neoplasm progression (3,221)
Fatigue (1,840)
Death (1,677)
Metastases to bone (1,525)
Nausea (1,510)
Neutropenia (1,486)
Metastases to liver (1,241)
Breast cancer metastatic (1,165)
Diarrhoea (1,163)
Dyspnoea (858)
What Other Drugs Cause Breast cancer recurrent?
LETROZOLE (285)
TRASTUZUMAB (268)
TAMOXIFEN (260)
ANASTROZOLE (214)
CYCLOPHOSPHAMIDE (182)
RIBOCICLIB (180)
PACLITAXEL (151)
DOCETAXEL (138)
PALBOCICLIB (126)
DOXORUBICIN (114)
Which FULVESTRANT Alternatives Have Lower Breast cancer recurrent Risk?
FULVESTRANT vs FURAZOLIDONE
FULVESTRANT vs FUROSEMIDE
FULVESTRANT vs FUROSEMIDE\SPIRONOLACTONE
FULVESTRANT vs FUSIDATE
FULVESTRANT vs FUSIDIC ACID